Exploration for drug therapy in endometrial carcinoma

Chinese Medical Journal

Volumn 109, Issue 5, 1996, Pages 356-360

  Zhang, Xiyin ^a   Cao, Binrong ^a  

^a OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; HYDROXYPROGESTERONE CAPROATE; LUTEINIZING HORMONE; PREDNISONE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; DRUG EFFICACY; ENDOMETRIUM CANCER; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; AMINOGLUTETHIMIDE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, SQUAMOUS CELL; DOUBLE-BLIND METHOD; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYDROXYPROGESTERONES; MIDDLE AGED; TAMOXIFEN;

EID: 0029887376     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Quinn UA. Tamoxifen therapy in advanced recurrent endometrial carcinoma. Gynecol Oncol 1989; 32:1.
2. Hiort O. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Am J Clin Pathol 1990; 94:247.
3. Feng YJ, Zhang XY. Quantitative changes of progesterone receptor in MPA therapy of endometrial carcinoma. Chin J Obstet Gynecol 1989; 3:153.
4. Allan L, Richard JS. Medical adrenolectomy using aminoglutethimide and dexamethasone in advanced breast cancer. Cancer 1974; 33:504.
5. Harold AH, Richard JS, Jura JO, et al. A competitive trial of transphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer, Cancer 1979; 43:2207.
6. Lawrence BV, Lipton A. Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy. Cancer 1980; 45:786.